Skip to main content
SpringerLink
Log in

Biomarkers in Sepsis

  • Chapter
  • First Online:
Sepsis

  • 4185 Accesses

Abstract

Sepsis is a global public health problem and generates more than 3,000,000 hospitalizations per year. Despite advances in modern medicine, it remains the leading cause of death in the critically ill patient in noncoronary intensive care units, with an estimated overall mortality of about 30%, corresponding to 5.3 million deaths a year [1–5]. To improve survival, early recognition of sepsis has become the primary goal of many societies, promoting research and thus promoting the development of new biomarkers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rhodes A, Evans L, Alhazzani W, Levy MM, Antonelli M, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304–77.

    Article  PubMed  Google Scholar 

  2. Winters BD, Eberlein M, Leung J, et al. Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med. 2010;38:1276–83.

    Article  PubMed  Google Scholar 

  3. Strehlow MC, Emond SD, Shapiro NI, et al. National study of emergency department visits for sepsis, 1992 to 2001. Ann Emerg Med. 2006;48:326–31.

    Article  PubMed  Google Scholar 

  4. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368.

    Article  CAS  PubMed  Google Scholar 

  5. Clerico A, Plebani M. Biomarkers for sepsis: an unfinished journey. Clin Chem Lab Med. 2013;51(6):1135–8.

    Article  CAS  PubMed  Google Scholar 

  6. Biron BM, Ayala A, Lomas-Neira JL. Biomarkers for sepsis: what is and what might be? Biomark Insights. 2015;10(Suppl 4):7–17.

    PubMed  PubMed Central  Google Scholar 

  7. Karzai W, Oberhoffer M, Meier-Hellmann A, Reinhart K. Procalcitonin: a new indicator of the systemic response to severe infections. Infection. 1997;25:329–34.

    Article  CAS  PubMed  Google Scholar 

  8. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448–54.

    Article  CAS  PubMed  Google Scholar 

  9. Tillett WS, Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med. 1930;52:561–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Faix JD. Biomarkers of sepsis. Crit Rev Clin Lab Sci. 2013;50(1):23–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341(8844):515–8.

    Article  CAS  PubMed  Google Scholar 

  12. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent J-L, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003;31:1250–6.

    Article  PubMed  Google Scholar 

  13. O’Grady NP, Barie PS, Bartlett JG, Bleck T, Carroll K, Kalil AC, Linden P, Maki DG, Nierman D, Pasculle W, Masur H. Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med. 2008;36:1330–49.

    Article  PubMed  Google Scholar 

  14. Chesi G, Vazzana N, Giumelli C. Biomarkers for sepsis: past, present and future. Ital J Med. 2016;10(4):301–9.

    Article  Google Scholar 

  15. Tillett WS, Francis T. serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med. 1930;52(4):561–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Rivers EP, Jaehne AK, Nguyen HB, et al. Early biomarker activity in severe sepsis and septic shock and a contemporary review of immunotherapy trials: not a time to give up, but to give it earlier. Shock. 2013;39(2):127–37.

    CAS  PubMed  Google Scholar 

  17. Schuetz P, Aujesky D, Mueller C, et al. Biomarker-guided personalised emergency medicine for all – hope for another hype? Swiss Med Wkly. 2015;145:w14079.

    PubMed  Google Scholar 

  18. Lelubre C, Anselin S, Boudjeltia KZ, Biston P, Piagnerelli M. Interpretation of C-reactive protein concentrations in critically ill patients. Biomed Res Int. 2013;2013:124021.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Zhang Z. HNI: C-reactive protein as a predictor of mortality in critically ill patients: a meta-analysis and systematic review. Anaesth Intensive Care. 2011;39:787–988.

    CAS  Google Scholar 

  20. Shine B, de Beer FC, Pepys MB. Solid phase radioimmunoassays for human C-reactive protein. Clin Chim Acta. 1981;117:13–23.

    Article  CAS  PubMed  Google Scholar 

  21. Prucha M, Bellingan G, Zazula R. Sepsis biomarkers. Clin Chim Acta. 2015;440:97–103.

    Article  CAS  PubMed  Google Scholar 

  22. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2014;13(5):426–35.

    Article  Google Scholar 

  23. Jensen JU, Hein L, Lundgren B, Bestle MH, Mohr TT, Andersen MH, et al. Procalcitonin and survival study (PASS) group: procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med. 2011;39:2048–58.

    Article  CAS  PubMed  Google Scholar 

  24. Liu D, Su L, Han G, Yan P, Xie L. Prognostic value of procalcitonin in adult patients with sepsis: a systematic review and meta-analysis. PLoS One. 2015;10(6):e0129450.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Arora S, Singh P, Singh PM, Trikha A. Procalcitonin levels in survivors and nonsurvivors of sepsis: systematic review and meta-analysis. Shock. 2015;43(3):212–21.

    Article  CAS  PubMed  Google Scholar 

  26. Prkno A, Wacker C, Brunkhorst FM, Schlattmann P. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock—a systematic review and meta-analysis. Crit Care. 2013;17(6):R291.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Soni NJ, Samson DJ, Galaydick JL, Vats V, Huang ES, Aronson N, Pitrak DL. Procalcitonin-guided antibiotic therapy: a systematic review and meta-analysis. J Hosp Med. 2013;8(9):530–40.

    Article  PubMed  Google Scholar 

  28. Chen K-F, Chaou C-H, Jiang J-Y, Yu H-W, Meng Y-H, Tang W-C, et al. Diagnostic accuracy of lipopolysaccharide-binding protein as biomarker for sepsis in adult patients: a systematic review and meta-analysis. PLoS One. 2016;11(4):e0153188.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Sakr Y, Burgett U, Nacul FE, Reinhart K, Brunkhorst F. Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis? Crit Care Med. 2008;36(7):2014–22.

    Article  CAS  PubMed  Google Scholar 

  30. Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, Palardy JE, et al. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis. 1999;180(5):1584–9.

    Article  CAS  PubMed  Google Scholar 

  31. Prucha M, Herold I, Zazula R, Dubska L, Dostal M, Hildebrand T, et al. Significance of lipopolysaccharide-binding protein (an acute phase protein) in monitoring critically ill patients. Crit Care. 2003;7(6):R154–9.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Nakamura M, Takeuchi T, Naito K, et al. Early elevation of plasma soluble CD14 subtype, a novel biomarker for sepsis, in a rabbit cecal ligation and puncture model. Crit Care. 2008;12(Suppl 2):P194. https://doi.org/10.1186/cc6415.

    Article  PubMed Central  Google Scholar 

  33. Nagata T, Yasuda Y, Ando M, et al. Clinical impact of kidney function on presepsin levels. PLoS One. 2015;10(6):e0129159.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Klouche K, Cristol JP, Devin J, et al. Diagnostic and prognostic value of soluble CD14 subtype (presepsin) for sepsis and community-acquired pneumonia in ICU patients. Ann Intensive Care. 2016;6:59.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A, Nishida T, Irie Y, Miura M, Iguchi H, Fukui Y, Tanaka K, Nojima T, Okamura Y. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother. 2012;18:891–7.

    Article  CAS  PubMed  Google Scholar 

  36. Lui B, Chen YX, Yin Q, Zhao YZ, Li CS. Diagnostic value and prognostic evaluation of presepsin for sepsis in an emergency depart. Crit Care. 2013;17(5):R244.

    Article  Google Scholar 

  37. Masson S, Caironi P, Spanuth E, et al. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the albumin Italian outcome sepsis trial. Crit Care. 2014;18(1):R6.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Zheng Z, Jiang L, Ye L, Gao Y, Tang L, Zhang M. The accuracy of presepsin for the diagnosis of sepsis from SIRS: a systematic review and meta-analysis. Ann Intensive Care. 2015;5(1):48.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Wu J, Hu L, Zhang G, Wu F, He T. Accuracy of presepsin in sepsis diagnosis: a systematic review and meta-analysis. PLoS One. 2015;10(7):e0133057.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Wu Y, Wang F, Fan X, Bao R, Bo L, Li J, Deng X. Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: a systematic review and meta-analysis. Crit Care. 2012;16(6):R229.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Su L, Liu D, Chai W, Liu D, Long Y. Role of sTREM-1 in predicting mortality of infection: a systematic review and meta-analysis. BMJ Open. 2016;6(5):e010314.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Chen Q, Shi J, Fei A, Wang F, Pan S, Wang W. Neutrophil CD64 expression is a predictor of mortality for patients in the intensive care unit. Int J Clin Exp Pathol. 2014;7(11):7806–13.

    PubMed  PubMed Central  Google Scholar 

  43. Farias MG, de Lucena NP, Dal Bó S, de Castro SM. Neutrophil CD64 expression as an important diagnostic marker of infection and sepsis in hospital patients. J Immunol Methods. 2014;414:65–8.

    Article  CAS  PubMed  Google Scholar 

  44. Groselj-Grenc M, Ihan A, Pavcnik-Arnol M, Kopitar AN, Gmeiner-Stopar T, Derganc M. Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children. Intensive Care Med. 2009;35(11):1950–8.

    Article  CAS  PubMed  Google Scholar 

  45. Wang X, Li ZY, Zeng L, Zhang AQ, Pan W, Gu W, Jiang JX. Neutrophil CD64 expression as a diagnostic marker for sepsis in adult patients: a meta-analysis. Crit Care. 2015;19:245.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Low C, Syed D, Khan D, Tetik S, Walborn A, Hoppensteadt D, Mosier M, Fareed J. Modulation of interleukins in sepsis-associated clotting disorders: interplay with hemostatic derangement. Clin Appl Thromb Hemost. 2017;23(1):34–9.

    Article  CAS  PubMed  Google Scholar 

  47. Zhao HQ, Li WM, Lu ZQ, Sheng ZY, Yao YM. The growing spectrum of anti-inflammatory interleukins and their potential roles in the development of sepsis. J Interf Cytokine Res. 2015;35(4):242–51.

    Article  CAS  Google Scholar 

  48. Hou T, Huang D, Zeng R, Ye Z, Zhang Y. Accuracy of serum interleukin (IL)-6 in sepsis diagnosis: a systematic review and meta-analysis. Int J Clin Exp Med. 2015;8(9):15238–45.

    PubMed  PubMed Central  Google Scholar 

  49. Pan W, Zhang AQ, Yue CL, Gao JW, Zeng L, Gu W, Jiang JX. Association between interleukin-10 polymorphisms and sepsis: a meta-analysis. Epidemiol Infect. 2015;143(2):366–75.

    Article  CAS  PubMed  Google Scholar 

  50. Liu Y, Hou JH, Li Q, Chen KJ, Wang SN, Wang JM. Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome: a systematic review and meta-analysis. Spring. 2016;5(1):2091.

    Article  Google Scholar 

  51. Bouaicha S, Blatter S, Moor BK, Spanaus K, Dora C, Werner CM. Nivel early procalcitonina en suero después de la sustitución total de cadera primaria. Los Med Inflamm. 2013;2013:927.636. https://doi.org/10.1155/2013/927636.

    Google Scholar 

  52. Amin DN, Pruitt JC, Schuetz P. Influence of major cardiopulmonary surgery on serum levels of procalcitonin and other inflammatory markers. Anaesth Intensive Care. 2012;40(5):760–6.

    CAS  PubMed  Google Scholar 

  53. Bouaicha S, Blatter S, Moor BK, Spanaus K, Dora C, Werner CM. Early serum procalcitonin level after primary total hip replacement. Mediat Inflamm. 2013;2013:927636.

    Article  Google Scholar 

  54. Varetto G, Castagno C, Trucco A, Frola E, Bert F, Scozzari G, Rispoli P. Serum procalcitonin as a valuable diagnostic tool in the early detection of infectious complications after open abdominal aortic repair. Ann Vasc Surg. 2016;34:111–8.

    Article  PubMed  Google Scholar 

  55. Kaido T, Ogawa K, Fujimoto Y, Mori A, Hatano E, Okajima H, Uemoto S. Perioperative changes of procalcitonin levels in patients undergoing liver transplantation. Transpl Infect Dis. 2014;16(5):790–6.

    Article  CAS  PubMed  Google Scholar 

  56. Kallel S, Abid M, Jarraya A, Abdenadher M, Mnif E, Frikha I, Ayadi F, Karoui A. Kinetics, diagnostic and prognostic value of procalcitonin after cardiac surgery. Ann Biol Clin. 2012;70(5):567–80.

    CAS  Google Scholar 

  57. Dong Z, Jianxin Z, Haraguchi G, Arai H, Mitaka C. Procalcitonin for the differential diagnosis of infectious and non-infectious systemic inflammatory response syndrome after cardiac operation. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014;26(7):478–9.

    PubMed  Google Scholar 

  58. Friederichs J, Hutter M, Hierholzer C, Novotny A, Friess H, Buhren V, Hungerer S. Procalcitonin ratio as a predictor of successful surgical treatment of severe necrotizing soft tissue infections. Am J Surg. 2013;206(3):368–73.

    Article  CAS  PubMed  Google Scholar 

  59. Omar AS, El Shawarby A, Singh R. Early monitoring of ventriculostomy-related infections with procalcitonin in patients with ventricular drains. J Clin Monit Comput. 2015;29(6):759–65.

    Article  PubMed  Google Scholar 

  60. Kraft R, Herndon DN, Finnerty CC, Cox RA, Song J, Jeschke MG. Predictive value of IL-8 for sepsis and severe infections after burn injury: a clinical study. Shock. 2015;43(3):222–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Ren H, Li Y, Han C, Hu H. Serum procalcitonin as a diagnostic biomarker for sepsis in burned patients: a meta-analysis. Burns. 2015;41(3):502–9.

    Article  PubMed  Google Scholar 

  62. Cakır Madenci Ö, Yakupoğlu S, Benzonana N, Yücel N, Akbaba D, Orçun-Kaptanağası A. Evaluation of soluble CD14 subtype (presepsin) in burn sepsis. Burns. 2014;40(4):664–9.

    Article  PubMed  Google Scholar 

  63. Massaro KS, Macedo R, de Castro BS, Dulley F, Oliveira MS, Yasuda MA, Levin AS, Costa SF. Risk factor for death in hematopoietic stem cell transplantation: are biomarkers useful to foresee the prognosis in this population of patients? Infection. 2014;42(6):1023–32.

    Article  CAS  PubMed  Google Scholar 

  64. Lyu YX, Yu XC, Zhu MY. Comparison of the diagnostic value of procalcitonin and C-reactive protein after hematopoietic stem cell transplantation: a systematic review and meta-analysis. Transpl Infect Dis. 2013;15(3):290–9.

    Article  CAS  PubMed  Google Scholar 

  65. Stoma I, Karpov I, Uss A, Rummo O, Milanovich N, Iskrov I. Diagnostic value of sepsis biomarkers in hematopoietic stem cell transplant recipients in a condition of high prevalence of gram-negative pathogens. Hematol Oncol Stem Cell Ther. 2017;10(1):15–21.

    Article  PubMed  Google Scholar 

  66. Yu XY, Wang Y, Zhong H, Dou QL, Song YL, Wen H. Diagnostic value of serum procalcitonin in solid organ transplant recipients: a systematic review and meta-analysis. Transplant Proc. 2014;46(1):26–32.

    Article  CAS  PubMed  Google Scholar 

  67. Cousin VL, Lambert K, Trabelsi S, Galetto-Lacour A, Posfay-Barbe KM, Wildhaber BE, McLin VA. Procalcitonin for infections in the first week after pediatric liver transplantation. BMC Infect Dis. 2017;17(1):149.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Desmard M, Benbara A, Boudinet S, Mal H, Dehoux M, Thabut G, Montravers P. Post-operative kinetics of procalcitonin after lung transplantation. J Heart Lung Transplant. 2015;34(2):189–94.

    Article  PubMed  Google Scholar 

  69. Zant R, Melter M, Knoppke B, Ameres M, Kunkel J. Kinetics of interleukin-6, procalcitonin, and C-reactive protein after pediatric liver transplantation. Transplant Proc. 2014;46(10):3507–10.

    Article  CAS  PubMed  Google Scholar 

  70. Yang Y, Xie J, Guo F, Longhini F, Gao Z, Huang Y, Qiu H. Combination of C-reactive protein, procalcitonin and sepsis-related organ failure score for the diagnosis of sepsis in critical patients. Ann Intensive Care. 2016;6(1):51.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Gibot S, Béné MC, Noel R, Massin F, Guy J, Cravoisy A, Barraud D, De Carvalho BM, Quenot JP, Bollaert PE, Faure G, Charles PE. Combination biomarkers to diagnose sepsis in the critically ill patient. Am J Respir Crit Care Med. 2012;186(1):65–71.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Internal Medicine, Critical Medicine and Intensive Care, Universidad de Cartagena, Cartagena, Colombia

    Mario Lora-Andosilla, Kevin Cantillo-García & Diana Borré-Naranjo

  2. Internal Medicine, Universidad Libre Barranquilla, Barranquilla, Colombia

    Melkis Buelvas-Villalba

  3. Department of Internal Medicine, Pulmonary Medicine and Critical Care Hospital Santa Clara, Universidad del Bosque, Bogotá, Colombia

    Guillermo Ortiz-Ruiz MD, PhD

  4. Postgraduate Program in Critical Medicine and Intensive Care, Universidad de Cartagena, Intensive Care Unit, Gestion Salud, Cartagena, Bolivar, Colombia

    Carmelo Dueñas-Castell

  5. Universidad del Bosque, Bogotá, Colombia

    Carmelo Dueñas-Castell

  6. Critical Care Medicine, Universidad de la Sabana, Cundinamarca, Colombia

    Carmelo Dueñas-Castell

Authors
  1. Mario Lora-Andosilla
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kevin Cantillo-García
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Diana Borré-Naranjo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Melkis Buelvas-Villalba
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guillermo Ortiz-Ruiz MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Carmelo Dueñas-Castell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carmelo Dueñas-Castell .

Editor information

Editors and Affiliations

  1. Department of Internal Medicine Pulmonary Medicine and Critical Care Hospital Santa Clara, Universidad del Bosque, Bogotá, Colombia

    Guillermo Ortiz-Ruiz

  2. Department of Critical Care Clínica Gestión Salud, Universidad de Cartagena, Cartagena, Colombia

    Carmelo Dueñas-Castell

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media LLC

About this chapter

Cite this chapter

Lora-Andosilla, M., Cantillo-García, K., Borré-Naranjo, D., Buelvas-Villalba, M., Ortiz-Ruiz, G., Dueñas-Castell, C. (2018). Biomarkers in Sepsis. In: Ortiz-Ruiz, G., Dueñas-Castell, C. (eds) Sepsis. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-7334-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7334-7_4

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-7332-3

  • Online ISBN: 978-1-4939-7334-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation